Related references
Note: Only part of the references are listed.Time trends of esophageal and gastric cancer mortality in China, 1991-2009: an age-period-cohort analysis
Mengmeng Li et al.
SCIENTIFIC REPORTS (2017)
Peroxiredoxin 1 promotes tumorigenesis through regulating the activity of mTOR/p70S6K pathway in esophageal squamous cell carcinoma
Fanghua Gong et al.
MEDICAL ONCOLOGY (2015)
Conformational switching of the 26S proteasome enables substrate degradation
Mary E. Matyskiela et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
Genetic polymorphisms in androgen receptor-binding sites predict survival in prostate cancer patients receiving androgen-deprivation therapy
C. -N. Huang et al.
ANNALS OF ONCOLOGY (2012)
Proteasome inhibition-induced p38 MAPK/ERK signaling regulates autophagy and apoptosis through the dual phosphorylation of glycogen synthase kinase 3β
Cheol-Hee Choi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Stromal proteome expression profile and muscle-invasive bladder cancer research
Haitao Niu et al.
CANCER CELL INTERNATIONAL (2012)
Novel Genetic Markers of Breast Cancer Survival Identified by a Genome-Wide Association Study
Xiao Ou Shu et al.
CANCER RESEARCH (2012)
Proteasome inhibition by quercetin triggers macroautophagy and blocks mTOR activity
Anja K. Klappan et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2012)
Proteasome deubiquitinases as novel targets for cancer therapy
Padraig D'Arcy et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Development of proteasome inhibitors as research tools and cancer drugs
Alfred L. Goldberg
JOURNAL OF CELL BIOLOGY (2012)
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
P. van Hagen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Functions and regulation of the 70 kDa ribosomal S6 kinases
Tim R. Fenton et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)
An Atlas of Altered Expression of Deubiquitinating Enzymes in Human Cancer
Chiara Luise et al.
PLOS ONE (2011)
Combination Therapy of Bortezomib with Novel Targeted Agents: An Emerging Treatment Strategy
John J. Wright
CLINICAL CANCER RESEARCH (2010)
The Ubiquitin-Proteasome System as a Prospective Molecular Target for Cancer Treatment and Prevention
Di Chen et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2010)
A Protein Interaction Network for Ecm29 Links the 26 S Proteasome to Molecular Motors and Endosomal Components
Carlos Gorbea et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Defining the Human Deubiquitinating Enzyme Interaction Landscape
Mathew E. Sowa et al.
CELL (2009)
Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2)
A. Arlt et al.
ONCOGENE (2009)
Targeting ubiquitin specific proteases for drug discovery
Laurent Daviet et al.
BIOCHIMIE (2008)
Proteasome inhibitors in cancer therapy: Lessons from the first decade
Robert Z. Orlowski et al.
CLINICAL CANCER RESEARCH (2008)
Proteomic expression analysis of surgical human colorectal cancer tissues: Up-regulation of PSB7, PRDX1, and SRP9 and hypoxic adaptation in cancer
Jung-hyun Rho et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Expression, purification, and characterization of a structurally disordered and functional C-terminal autoinhibitory domain (AID) of the 70 kDa 40S ribosomal protein S6 kinase-1 (S6K1)
Timothy J. Ragan et al.
PROTEIN EXPRESSION AND PURIFICATION (2008)
An activated mTOR/p70S6K signaling pathway in esophageal squamous cell carcinoma cell lines and inhibition of the pathway by rapamycin and siRNA against mTOR
Guiqin Hou et al.
CANCER LETTERS (2007)
The crystal structure of the human Mov34 MPN domain reveals a metal-free dimer
Mario Sanches et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Structural organization of the 19S proteasome lid: Insights from MS of intact complexes
Michal Sharon et al.
PLOS BIOLOGY (2006)
Bortezomib: efficacy comparisons in solid tumors and hematologic malignancies
Tommaso Caravita et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
Increased proteasome activity, ubiquitin-conjugating enzymes, and eEF1A translation factor detected in breast cancer tissue
L Chen et al.
CANCER RESEARCH (2005)
Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome
R Verma et al.
SCIENCE (2002)
Share Paper
